+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 1clu | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTP | ||||||
要素 | TRANSFORMING PROTEIN P21/H-RAS-1 | ||||||
キーワード | HYDROLASE / GTP HYDROLASE / SIGNAL TRANSDUCTION / CANCER / G-DOMAIN | ||||||
| 機能・相同性 | 機能・相同性情報phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of miRNA metabolic process / positive regulation of ruffle assembly / T-helper 1 type immune response / positive regulation of wound healing / defense response to protozoan / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / Signaling by RAS GAP mutants ...phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of miRNA metabolic process / positive regulation of ruffle assembly / T-helper 1 type immune response / positive regulation of wound healing / defense response to protozoan / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / positive regulation of protein targeting to membrane / SHC1 events in ERBB4 signaling / adipose tissue development / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Schwann cell development / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / FRS-mediated FGFR1 signaling / p38MAPK events / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / Signaling by FGFR2 in disease / myelination / EPHB-mediated forward signaling / GRB2 events in EGFR signaling / Signaling by FLT3 fusion proteins / SHC1 events in EGFR signaling / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / intrinsic apoptotic signaling pathway / Downstream signal transduction / GRB2 events in ERBB2 signaling / Insulin receptor signalling cascade / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / animal organ morphogenesis / VEGFR2 mediated cell proliferation / positive regulation of epithelial cell proliferation / small monomeric GTPase / regulation of actin cytoskeleton organization / positive regulation of JNK cascade / FCERI mediated MAPK activation / RAF activation / Signaling by ERBB2 TMD/JMD mutants / cellular response to gamma radiation / Signaling by SCF-KIT / Constitutive Signaling by EGFRvIII / Signaling by high-kinase activity BRAF mutants / regulation of long-term neuronal synaptic plasticity / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / positive regulation of type II interferon production / endocytosis / positive regulation of fibroblast proliferation / chemotaxis / Regulation of RAS by GAPs / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / cellular senescence / Signaling by BRAF and RAF1 fusions / insulin receptor signaling pathway / DAP12 signaling / T cell receptor signaling pathway / MAPK cascade / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / regulation of cell population proliferation / G protein activity 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / 分子置換 / 解像度: 1.7 Å | ||||||
データ登録者 | Ahmadian, M.R. / Zor, T. / Vogt, D. / Kabsch, W. / Selinger, Z. / Wittinghofer, A. / Scheffzek, K. | ||||||
引用 | ジャーナル: Proc.Natl.Acad.Sci.USA / 年: 1999タイトル: Guanosine triphosphatase stimulation of oncogenic Ras mutants. 著者: Ahmadian, M.R. / Zor, T. / Vogt, D. / Kabsch, W. / Selinger, Z. / Wittinghofer, A. / Scheffzek, K. #1: ジャーナル: Febs Lett. / 年: 1998 タイトル: GTP analogue hydrolysis by the Gs protein: implication for the role of catalytic glutamine in the GTPase reaction. 著者: Zor, T. / Andorn, R. / Sofer, I. / Chorev, M. / Selinger, Z. #2: ジャーナル: Eur.J.Biochem. / 年: 1997 タイトル: Rescue of a mutant G-protein by substrate-assisted catalysis. 著者: Zor, T. / Bar-Yaacov, M. / Elgavish, S. / Shaanan, B. / Selinger, Z. #3: ジャーナル: Biochemistry / 年: 1993タイトル: Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras. 著者: Franken, S.M. / Scheidig, A.J. / Krengel, U. / Rensland, H. / Lautwein, A. / Geyer, M. / Scheffzek, K. / Goody, R.S. / Kalbitzer, H.R. / Pai, E.F. #4: ジャーナル: Cell(Cambridge,Mass.) / 年: 1990タイトル: Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. 著者: Krengel, U. / Schlichting, I. / Scherer, A. / Schumann, R. / Frech, M. / John, J. / Kabsch, W. / Pai, E.F. / Wittinghofer, A. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 1clu.cif.gz | 49.2 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb1clu.ent.gz | 32.8 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 1clu.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/cl/1clu ftp://data.pdbj.org/pub/pdb/validation_reports/cl/1clu | HTTPS FTP |
|---|
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 18915.254 Da / 分子数: 1 / 断片: CATALYTIC DOMAIN, RESIDUES 1 - 166 / 変異: GLY12PRO / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: H-RAS-1 / 参照: UniProt: P01112 |
|---|---|
| #2: 化合物 | ChemComp-MG / |
| #3: 化合物 | ChemComp-DBG / |
| #4: 水 | ChemComp-HOH / |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 2 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2 Å3/Da / 溶媒含有率: 30 % | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 結晶化 | 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7.5 詳細: SEE REFERENCE DECRIBING THE STRUCTURE AND CITATIONS THEREIN, pH 7.5, VAPOR DIFFUSION, HANGING DROP | ||||||||||||||||||||||||||||||||||||||||||
| 結晶化 | *PLUS 手法: batch method | ||||||||||||||||||||||||||||||||||||||||||
| 溶液の組成 | *PLUS
|
-データ収集
| 回折 | 平均測定温度: 277 K |
|---|---|
| 放射光源 | 由来: 回転陽極 / タイプ: ELLIOTT GX-18 / 波長: 1.5418 |
| 検出器 | タイプ: SIEMENS / 検出器: AREA DETECTOR / 日付: 1998年4月9日 / 詳細: MIRRORS |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.5418 Å / 相対比: 1 |
| 反射 | 解像度: 1.7→100 Å / % possible obs: 99 % / 冗長度: 8.7 % / Biso Wilson estimate: 15.5 Å2 / Rmerge(I) obs: 0.084 / Rsym value: 0.084 / Net I/σ(I): 15.2 |
| 反射 シェル | 解像度: 1.7→1.75 Å / 冗長度: 3.4 % / Rmerge(I) obs: 0.26 / Mean I/σ(I) obs: 2.5 / Rsym value: 0.26 / % possible all: 95.3 |
| 反射 | *PLUS Num. obs: 17463 / Num. measured all: 151581 |
| 反射 シェル | *PLUS % possible obs: 95.3 % |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: 5P21 解像度: 1.7→5 Å / Rfactor Rfree error: 0.006 / Data cutoff high absF: 100000 / Data cutoff low absF: 0.001 / Isotropic thermal model: RESTRAINED / 交差検証法: THROUGHOUT / σ(F): 0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 22.1 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine analyze |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 1.7→5 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 1.7→1.8 Å / Rfactor Rfree error: 0.018 / Total num. of bins used: 6
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ソフトウェア | *PLUS 名称: X-PLOR / バージョン: 3.851 / 分類: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 | *PLUS Rfactor obs: 0.203 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 | *PLUS
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用











PDBj






















